# EDGAR Filing Document

**Accession Number:** 0001066923
**File Stem:** 0001213900-26-062948
**Filing Date:** 2026-5
**Character Count:** 55409
**Document Hash:** 67a9d74c164d7fe101f3015acb466b7f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-062948.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001213900-26-062948

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 16

**FILED AS OF DATE**: 20260529

**DATE AS OF CHANGE**: 20260529

**EFFECTIVENESS DATE**: 20260529

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Future FinTech Group Inc.
- **CENTRAL INDEX KEY:** 0001066923
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 980222013
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296375
- **FILM NUMBER:** 261046014

**BUSINESS ADDRESS:**
- **STREET 1:** AMERICAS TOWER, 1177 AVENUE OF THE AMERI
- **STREET 2:** SUITE 5100
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 888-622-1218

**MAIL ADDRESS:**
- **STREET 1:** AMERICAS TOWER, 1177 AVENUE OF THE AMERI
- **STREET 2:** SUITE 5100
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SkyPeople Fruit Juice, Inc
- **DATE OF NAME CHANGE:** 20080610

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ENTECH ENVIRONMENTAL TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 20040323

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CYBER PUBLIC RELATIONS INC
- **DATE OF NAME CHANGE:** 20010111

**As filed with the Securities and Exchange Commission on May 29, 2026**

**Registration No. 333-[___]**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

**FUTURE FINTECH GROUP INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Florida** | **98-0222013** |
| (State or Other Jurisdiction of | (I.R.S. Employer |
| Incorporation or Organization) | Identification No.) |

---

**02B-03A, 23/F, Sino Plaza, 255-257 Gloucester Road**

**Causeway Bay, Hong Kong**

**N/A**

(Address of Principal Executive Offices) (Zip Code)

**Future FinTech Group Inc. 2025 Omnibus Equity Plan**

(Full title of the plan)

**COGENCY GLOBAL INC.**

**122 E. 42ND ST**

**18th Fl.**

**NEW YORK, NY 10168**

**P: 800.221.0102**

**F: 800.944.6607**

(Name, address and telephone number, including area code, of agent for service)

Copies to:

**Laura Hemmann, Esq.**

**iTKG Law LLC**

**100 Corporate Drive, Suite 302**

**Lebanon, NJ 08833**

**United States**

**+1 (835)-222-4854**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 is being filed by Future FinTech Group Inc., a Florida corporation (the "Registrant"), to register 1,250,000 shares of common stock, par value $0.001 per share ("Common Stock"), issuable under the Future FinTech Group Inc. 2025 Omnibus Equity Plan (the "Plan"). The Future FinTech Group Inc. 2025 Omnibus Equity Plan originally authorized 5,000,000 shares of common stock for issuance thereunder. The share amount registered hereby reflects the proportional adjustment of such share reserve to 1,250,000 shares as a result of the Registrant's 1-for-4 reverse stock split effected in January 2026, pursuant to the adjustment provisions of the Plan.

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS**

The documents containing the information specified in Part I of Form S-8 will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the "Securities Act"). In accordance with the rules and regulations of the Securities and Exchange Commission (the "Commission"), such documents are not being filed with the Commission as part of this Registration Statement on Form S-8 (this "Registration Statement") or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. Such documents, together with the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II hereof, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference**

The following documents filed by the Registrant with the Commission are incorporated by reference in this Registration Statement:

● the Registrant's Annual Report on [Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1066923/000121390026030833/ea0277943-10k_future.htm) for the fiscal year ended December 31, 2025, filed with the Commission on March 18, 2026;

● the Registrant's Current Report on [Form 8-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1066923/000121390025122774/ea0269925-8k_future.htm) filed with the Commission on December 17, 2025, to the extent filed and not furnished;

● all other reports filed by the Registrant pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), since December 31, 2025, to the extent filed and not furnished; and

● the description of the Registrant's Common Stock contained in the Registrant's registration statement filed under Section 12 of the Exchange Act, including any amendment or report filed for the purpose of updating such description, including the description of securities filed as [Exhibit 4.1](https://www.sec.gov/Archives/edgar/data/1066923/000121390026030833/ea027794301ex4-1.htm) to the Registrant's Annual Report on [Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1066923/000121390026030833/ea0277943-10k_future.htm) for the fiscal year ended December 31, 2025.

All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents, reports or portions thereof that are deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 4. Description of Securities**

Not applicable. The Common Stock is registered under Section 12(b) of the Exchange Act.

**Item 5. Interests of Named Experts and Counsel**

Not applicable.

**Item 6. Indemnification of Directors and Officers**

The Registrant is incorporated under the laws of the State of Florida. The Florida Business Corporation Act provides, among other things, that a Florida corporation may indemnify a person who is a party to a proceeding because the person is or was a director or officer of the corporation against liability incurred in the proceeding if the person acted in good faith and in a manner the person reasonably believed to be in, or not opposed to, the best interests of the corporation and, in the case of a criminal proceeding, had no reasonable cause to believe the person's conduct was unlawful. The Florida Business Corporation Act also provides for mandatory indemnification in certain circumstances and permits advancement of expenses, subject to the limitations and procedures set forth therein.

The Registrant's articles of incorporation, bylaws and indemnification agreements may provide for indemnification and advancement of expenses to directors and officers to the fullest extent permitted by applicable law, subject to the limitations of the Florida Business Corporation Act and other applicable law. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or controlling persons of the Registrant pursuant to the foregoing provisions, the Registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

**Item 7. Exemption from Registration Claimed**

Not applicable.

**Item 8. Exhibits**

The exhibits listed in the Exhibit Index immediately preceding the signature page are filed as part of, or incorporated by reference in, this Registration Statement.

**Item 9. Undertakings**

(a) The undersigned Registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement, or the most recent post-effective amendment thereof, which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered, if the total dollar value of securities offered would not exceed that which was registered, and any deviation from the low or high end of the estimated maximum offering range, may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Filing Fee Tables" or "Calculation of Registration Fee" table, as applicable, in the effective registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act, and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act, that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding, is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| Exhibit<br> Number | Description |
| 4.1 | [Second Amended and Restated Articles of Incorporation, dated June 6, 2017 (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on June 9, 2017).](https://www.sec.gov/Archives/edgar/data/1066923/000121390017006308/f8k060617ex3i_futurefintech.htm) |
| 4.2 | [Articles of Amendment to the Second Amended and Restated Articles of Incorporation filed with the Department of State of Florida on March 27, 2025 (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on April 1, 2025).](https://www.sec.gov/Archives/edgar/data/1066923/000121390025027130/ea023592001ex3-1_future.htm) |
| 4.3 | [Articles of Amendment to the Second Amended and Restated Articles of Incorporation filed with the Department of State of Florida on September 8, 2025 (incorporated by reference to Exhibit 3.8 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2025).](https://www.sec.gov/Archives/edgar/data/1066923/000121390026030833/ea027794301ex3-8.htm) |
| 4.4 | [Articles of Amendment to the Second Amended and Restated Articles of Incorporation filed with the Department of State of Florida on January 8, 2026 (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on January 14, 2026).](https://www.sec.gov/Archives/edgar/data/1066923/000121390026004240/ea027272201ex3-1_future.htm) |
| 4.5 | [Amended and Restated Bylaws, dated August 6, 2025 (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on August 26, 2025).](http://www.sec.gov/Archives/edgar/data/1066923/000121390025080776/ea025463601ex3-1_future.htm) |
| 4.6 | [Description of the Registrant's Common Stock registered under Section 12 of the Exchange Act (incorporated by reference to Exhibit 4.1 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2025).](https://www.sec.gov/Archives/edgar/data/1066923/000121390026030833/ea027794301ex4-1.htm) |
| 4.7 | [Future FinTech Group Inc. 2025 Omnibus Equity Plan.](ea029244101ex4-7.htm) |
| 5.1 | [Opinion of Anthony, Linder & Cacomanolis, PLLC regarding the legality of the shares being registered.](ea029244101ex5-1.htm) |
| 23.1 | [Consent of Fortune CPA, Inc.](ea029244101ex23-1.htm) |
| 23.2 | [Consent of Anthony, Linder & Cacomanolis, PLLC (included in Exhibit 5.1).](ea029244101ex5-1.htm) |
| 24.1 | [Power of Attorney (included on the signature page to this Registration Statement).](#poa_001) |
| 107 | [Filing Fee Table.](ea029244101ex-fee.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Causeway Bay, Hong Kong, on May 29, 2026.

---

| | |
|:---|:---|
| FUTURE FINTECH GROUP INC. | FUTURE FINTECH GROUP INC. |
| By: | */s/ Hu Li* |
| Name: | Hu Li |
| Title: | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Hu Li as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this Registration Statement, and to file the same, with all exhibits thereto and all other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitute may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ Hu Li | Chief Executive Officer and Director | May 29, 2026 |
| Hu Li | (Principal Executive Officer) |  |
| /s/ Ting Ouyang | Chief Financial Officer and Director | May 29, 2026 |
| Ting Ouyang | (Principal Financial Officer and Principal Accounting Officer) |  |
| /s/ Mingyong Hu | Director | May 29, 2026 |
| Mingyong Hu |  |  |
| /s/ Mingjie Zhao | Director | May 29, 2026 |
| Mingjie Zhao |  |  |
| /s/ David Xu | Director | May 29, 2026 |
| David Xu |  |  |

---

## Exhibit 4.7

**Exhibit 4.7**

**CONFIDENTIAL**

**THIS DOCUMENT CONSTITUTES PART OF A SECTION 10(a) PROSPECTUS COVERING SECURITIES THAT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933.**

**SUMMARY DESCRIPTION**

**OF THE**

**FUTURE FINTECH GROUP INC.**

**2025 OMNIBUS EQUITY PLAN**

Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this Summary. Any representation to the contrary is a criminal offense.

The date of this Summary Description is [●], 2026.

**Index**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General Information about the 2025 Plan | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration of the 2025 Plan | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares Subject to the 2025 Plan | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Types of Awards Available under the 2025 Plan | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term of the 2025 Plan | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eligibility | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock Appreciation Rights | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted Stock, Unrestricted Stock and Restricted Stock Units | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination of Service, Forfeiture and Acceleration | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restrictions on Transferability | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments, Reorganizations and Change of Control | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendment, Modification and Termination | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Summary of Tax Consequences of the 2025 Plan for U.S. Participants | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Note for Non-U.S. Participants | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where You Can Find More Information | 7 |

---

i

**General Information about the 2025 Plan**

The Future FinTech Group Inc. 2025 Omnibus Equity Plan (the "2025 Plan") and this Summary Description of the 2025 Plan together constitute the Section 10(a) prospectus required to be delivered under the Securities Act of 1933, as amended (the "Securities Act"), with respect to the common stock, par value $0.001 per share ("Common Stock"), of Future FinTech Group Inc., a Florida corporation ("Future FinTech" or the "Company"), registered on Form S-8 for issuance under the 2025 Plan.

The 2025 Plan was adopted by the Board of Directors of the Company (the "Board") before the Company's one-for-ten reverse stock split effective April 1, 2025 and one-for-four reverse stock split effective January 20, 2026, and was approved by the Company's shareholders at the Company's 2025 annual meeting of shareholders held on December 12, 2025. The 2025 Plan is intended to attract and retain high caliber employees, directors, consultants and advisors, motivate participants to achieve long-range goals, provide competitive incentive compensation opportunities, and further align participants' interests with those of the Company's shareholders through compensation based on the Company's Common Stock.

This Summary is only a summary of certain provisions of the 2025 Plan and related tax considerations. It is qualified in its entirety by the full text of the 2025 Plan and the applicable award agreement. If there is any conflict between this Summary and the official 2025 Plan or applicable award agreement, the official 2025 Plan and applicable award agreement will control. Capitalized terms used but not defined in this Summary have the meanings given to them in the 2025 Plan.

**Administration of the 2025 Plan**

The 2025 Plan is administered and interpreted by the Committee designated under the 2025 Plan. The Board appoints the Committee from among its nonemployee members. Subject to the express provisions of the 2025 Plan, the Committee has authority to interpret the 2025 Plan, prescribe, amend and rescind rules and regulations relating to the 2025 Plan, determine the terms and provisions of award agreements, and make all other determinations necessary or advisable for administration of the 2025 Plan. Committee determinations are final, binding and conclusive.

The Committee decides which eligible persons will receive awards, when awards will be granted, the type and number of shares covered by awards, and the terms, conditions, performance criteria, restrictions and other provisions of awards. Unless prohibited by applicable law or stock exchange rules, the Committee may allocate responsibilities and powers to members of the Committee and may delegate administrative duties and powers to employees, including officers.

**Shares Subject to the 2025 Plan**

The shares issuable under the 2025 Plan are shares of the Company's authorized but unissued or reacquired Common Stock, including shares repurchased by the Company as treasury shares. The maximum number of shares available for issuance under the 2025 Plan, as originally stated in the 2025 Plan, as originally approved by the Company's shareholders at the Company's 2025 annual meeting of shareholders held on December 12, 2025, was 5,000,000 shares of Common Stock, subject to adjustment under the 2025 Plan. On January 20, 2026, the Company effected a one-for-four reverse stock split of its Common Stock. Giving effect to that reverse stock split, the share reserve under the 2025 Plan was proportionately adjusted to 1,250,000 shares of Common Stock.

Shares subject to awards that are forfeited, canceled or not delivered because an award contingency or condition is not satisfied generally may again become available for issuance under new awards, subject to the share counting rules in the 2025 Plan. Shares used to pay the exercise price of an option or withheld to satisfy withholding taxes are treated as issued and are not available for subsequent issuance under the 2025 Plan. Shares repurchased by the Company using option exercise proceeds and the total number of shares underlying a stock appreciation right that is exercised, whether settled in cash, shares or a combination, also are not available for subsequent issuance.

Subject to adjustment as provided in the 2025 Plan, the maximum aggregate number of shares that may be granted to any participant in any calendar year was 1,000,000 shares as originally stated in the 2025 Plan. Because that limit was stated before giving effect to the Company's one-for-four reverse stock splits, the adjusted annual participant limit is 250,000 shares, subject to the adjustment provisions of the 2025 Plan, fractional-share treatment and any applicable Committee determination. The maximum aggregate cash amount payable under the 2025 Plan for awards intended to constitute performance-based compensation to any participant in any single calendar year is $1,000,000.

**Types of Awards Available under the 2025 Plan**

The 2025 Plan permits the Committee to grant the following types of awards:

● Options, including incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), and non-statutory stock options;

● stock appreciation rights, or SARs;

● restricted stock;

● unrestricted stock; and

● restricted stock units, or RSUs.

Each award will be evidenced by an award agreement approved by the Committee. Award agreements need not be identical and may contain terms, conditions, performance criteria, restrictions and other provisions determined by the Committee, subject to the terms of the 2025 Plan.

**Term of the 2025 Plan**

The 2025 Plan became effective upon its adoption by the Board, subject to approval by the Company's shareholders, which approval was obtained at the Company's 2025 annual meeting of shareholders held on December 12, 2025. The 2025 Plan will terminate upon the earliest to occur of the tenth anniversary of the effective date of the 2025 Plan or the date on which all shares available for issuance under the 2025 Plan have been issued as fully vested shares. If the 2025 Plan terminates on the tenth anniversary of the effective date, awards then outstanding will continue to have force and effect in accordance with the applicable award agreements.

**Eligibility**

Persons eligible to participate in the 2025 Plan include employees, nonemployee members of the Board or of the board of directors of any related corporation, consultants and independent advisors who provide bona fide services to the Company or any related corporation, and persons who have been offered employment by the Company or a related corporation, subject to the limitations in the 2025 Plan. Incentive stock options may be granted only to employees.

No eligible person has a right to receive an award under the 2025 Plan. The Committee selects participants from among eligible persons and determines the nature and amount of each award.

**Options**

An option entitles the participant to purchase the number of shares designated in the applicable award agreement at an exercise price established by the Committee. Options may be incentive stock options or non-statutory stock options, as determined by the Committee. No incentive stock option may be granted more than ten years after the effective date of the 2025 Plan.

Each option will vest and become exercisable at the time or times, during the period, and for the number of shares determined by the Committee and set forth in the applicable award agreement. Vesting may be conditioned on continued service, achievement of performance conditions measured on an individual, corporate or other basis, or any combination of these conditions. No option may be exercisable after the expiration of ten years from the date of grant, or five years in the case of an incentive stock option granted to a 10% shareholder.

The exercise price for any option may not be less than 100% of the fair market value per share of Common Stock on the grant date, or 110% of fair market value in the case of an incentive stock option granted to a 10% shareholder. The exercise price may be paid in the forms permitted by the Committee, including cash or check, delivery or attestation of shares owned by the participant, withholding of shares that would otherwise be acquired on exercise, cashless exercise through a broker, or other legal consideration acceptable to the Committee, in each case subject to applicable law and the terms of the 2025 Plan.

To the extent the aggregate fair market value of shares subject to incentive stock options that first become exercisable by a participant during any calendar year exceeds $100,000, the excess options will be treated as non-statutory stock options.

**Stock Appreciation Rights**

A SAR entitles the participant to receive, with respect to each share subject to the SAR, the appreciation in fair market value over a base price established by the Committee. The base price per share may not be less than the fair market value per share of Common Stock on the grant date. Upon exercise, the participant will receive an amount equal to the excess of the fair market value of a share on the surrender date over the base price, multiplied by the number of shares covered by the SAR being exercised. The Committee determines whether payment will be made in cash, shares of Common Stock or a combination of both, and may provide that the spread covered by a SAR may not exceed a specified amount. A SAR generally may not be exercisable more than ten years after the date of grant unless otherwise determined by the Committee and set forth in the award agreement.

**Restricted Stock, Unrestricted Stock and Restricted Stock Units**

A restricted stock award is a grant of shares of Common Stock subject to conditions and restrictions determined by the Committee. During the applicable period of restriction, a restricted stock award may be subject to conditions, restrictions and contingencies determined by the Committee, including continued service or performance conditions.

The Committee may award unrestricted stock to any participant as a stock bonus or otherwise, pursuant to which the participant may receive shares of Common Stock free of restrictions or limitations that otherwise would apply to restricted stock under the 2025 Plan.

An RSU award entitles the participant to receive shares of Common Stock upon vesting of the award. RSUs may be granted in such amounts, upon such terms, and at such times as determined by the Committee. Each RSU will be subject to vesting conditions, restrictions and contingencies set forth in the applicable award agreement. As soon as practicable following the date each RSU vests, the Company will deliver to the participant the share underlying the vested RSU, subject to conditions, restrictions and contingencies established by the Committee.

**Termination of Service, Forfeiture and Acceleration**

Unless otherwise determined by the Committee and included in a participant's award agreement, if a participant's service with the Company and all related corporations is terminated for any reason, all awards held by the participant that are unexercised or have not yet vested as of the termination date will expire, terminate and become unexercisable as of that date. However, if the participant's service terminates for reasons other than cause, outstanding vested options and SARs held by the participant as of the termination date will continue to be exercisable until the earlier of the expiration of their term or the date that is three months after the termination date.

The Committee has discretion, subject to the terms of the 2025 Plan, to accelerate the vesting of, or lapse of restrictions on, any award. The Committee also has discretion to extend the period during which an option or SAR may remain exercisable following termination of service, but not beyond the expiration of the option or SAR term. An extension may result in recharacterization of an incentive stock option as a non-statutory stock option.

**Restrictions on Transferability**

All rights with respect to an award generally are available during a participant's lifetime only to the participant, except as designated by the participant by will or by the laws of descent and distribution. The Committee may provide that an award other than an incentive stock option may, in connection with the participant's estate plan, be assigned during the participant's lifetime to a trust established exclusively for one or more members of the participant's immediate family, subject to the same terms applicable to the award immediately before the assignment and any documents or procedures required by the Committee. A participant may also designate beneficiaries to receive benefits under outstanding awards after the participant's death.

**Adjustments, Reorganizations and Change of Control**

If the Company is involved in a corporate transaction or other event affecting the Common Stock, including a recapitalization, reclassification, reverse or forward stock split, stock dividend, extraordinary cash dividend, split-up, spin-off, combination or exchange of shares, the Committee will adjust awards in the manner provided in the 2025 Plan to preserve the benefits or potential benefits of the awards. Adjustments may include changes to the number and kind of shares issuable under the 2025 Plan, the maximum limits for grants, the number and kind of shares subject to outstanding awards, and the exercise price or base price of outstanding options and SARs. Only whole shares will be issued in making adjustments.

If the Company is part of a reorganization involving a merger, consolidation, acquisition of Common Stock or acquisition of the assets of the Company, the Committee may determine, among other things, that outstanding awards will apply to securities of the resulting corporation, that options or SARs will become fully exercisable and remain exercisable for their remaining term, that options or SARs will become fully exercisable and terminate after notice, or that unvested restricted stock and RSUs will become fully vested, nonforfeitable and payable.

The 2025 Plan also defines "Change of Control" for purposes of the 2025 Plan. The definition includes certain acquisitions of Company stock, certain changes in the composition of the Board, certain acquisitions of voting power, and certain acquisitions of Company assets, in each case subject to the detailed requirements and exceptions set forth in the 2025 Plan.

**Amendment, Modification and Termination**

Subject to the restrictions in the 2025 Plan, the Board may at any time add to, amend, modify or repeal provisions of the 2025 Plan, suspend operation of the entire 2025 Plan or any provision, or terminate the 2025 Plan in whole or in part. The Committee may amend any award agreement previously authorized under the 2025 Plan and the applicable participant, provided that no award agreement may be amended to reprice or constructively reprice any award.

No amendment, modification, repeal, suspension or termination may adversely affect the rights of participants who have outstanding awards without the consent of those participants. Shareholder approval is required for certain modifications described in the 2025 Plan, including modifications that would cause applicable portions of the 2025 Plan to fail to qualify as an incentive stock option plan under Code Section 422, materially increase benefits accruing to participants, materially increase the number of securities that may be issued under the 2025 Plan, or materially modify eligibility requirements, in each case subject to the detailed provisions of the 2025 Plan and applicable law.

Except in connection with specified corporate transactions, the terms of outstanding awards may not be amended to reduce the exercise price of outstanding options or the base price of SARs, or to cancel outstanding options or SARs in exchange for cash, other awards or options or SARs with a lower exercise price or base price, without shareholder approval.

**Summary of Tax Consequences of the 2025 Plan for U.S. Participants**

The following is a general summary under current U.S. federal income tax law of certain material federal income tax consequences to U.S. participants in the 2025 Plan. This summary is provided only for general information and does not address all federal tax consequences that may be relevant to a participant in light of the participant's particular circumstances. It also does not discuss state, local, employment, Medicare, foreign or other tax consequences. Tax laws are complex, subject to change, and may vary depending on individual circumstances. This Summary is not tax advice. Participants should consult their own tax advisors regarding the U.S. federal, state, local and foreign income and other tax consequences of awards under the 2025 Plan and of acquiring, holding and disposing of shares of Common Stock.

**Non-Statutory Stock Options**

A participant generally will not recognize taxable income at the time a non-statutory stock option is granted. Upon exercise, the participant generally will recognize ordinary compensation income equal to the excess of the fair market value of the shares acquired on the exercise date over the exercise price paid for those shares. The Company generally will be entitled to a corresponding deduction, subject to applicable limitations, including Code Section 162(m). Upon a later sale or other disposition of the shares, the participant generally will recognize capital gain or loss equal to the difference between the amount realized and the participant's tax basis in the shares. The tax basis generally will equal the fair market value of the shares on the exercise date.

**Incentive Stock Options**

A participant generally will not recognize regular taxable income at the time an incentive stock option is granted or, if applicable holding period and other requirements are satisfied, when the incentive stock option is exercised. However, the excess of the fair market value of the shares acquired on exercise over the exercise price may be an adjustment item for alternative minimum tax purposes. If the participant holds the shares acquired upon exercise of an incentive stock option for at least two years after the grant date and one year after the exercise date, any gain or loss on a later sale generally will be long-term capital gain or loss, and the Company generally will not be entitled to a deduction.

If a participant disposes of shares acquired upon exercise of an incentive stock option before satisfying these holding period requirements, the participant generally will recognize ordinary compensation income in the year of disposition equal to the lesser of the excess of the fair market value of the shares on the exercise date over the exercise price or the excess of the amount realized on disposition over the exercise price. Any additional gain or loss generally will be capital gain or loss. The Company generally will be entitled to a corresponding deduction, subject to applicable limitations, including Code Section 162(m).

**Stock Appreciation Rights**

A participant generally will not recognize taxable income at the time a SAR is granted. Upon exercise of a SAR, the participant generally will recognize ordinary compensation income equal to the amount of cash and the fair market value of any shares received. The Company generally will be entitled to a corresponding deduction at that time, subject to applicable limitations, including Code Section 162(m).

**Restricted Stock**

A participant generally will not recognize taxable income upon the grant of restricted stock unless the participant makes a timely election under Code Section 83(b). Absent such an election, the participant generally will recognize ordinary compensation income when the shares are no longer subject to a substantial risk of forfeiture or become transferable, in an amount equal to the fair market value of the shares at that time, reduced by any amount paid for the shares. If a timely Code Section 83(b) election is made, the participant generally will recognize ordinary compensation income at the time of grant equal to the fair market value of the shares at that time, reduced by any amount paid for the shares, and generally will not recognize additional ordinary income when the restrictions lapse. A Code Section 83(b) election must be filed within 30 days after the date the restricted stock is transferred. Participants should consult their tax advisors before making any Code Section 83(b) election.

**Restricted Stock Units**

A participant generally will not recognize taxable income at the time an RSU is granted. The participant generally will recognize ordinary compensation income when the RSU is settled, in an amount equal to the fair market value of the shares and any cash received. The Company generally will be entitled to a corresponding deduction at that time, subject to applicable limitations, including Code Section 162(m).

**Code Section 162(m)**

Code Section 162(m) generally limits the Company's deduction for compensation paid to certain covered employees to $1 million per year. Covered employees generally include certain current and former executive officers. Compensation attributable to awards under the 2025 Plan may be subject to this limitation.

**Code Section 409A**

Certain awards under the 2025 Plan may be subject to Code Section 409A, which imposes requirements on nonqualified deferred compensation. If an award is subject to Code Section 409A and fails to comply with or be exempt from Code Section 409A, the participant may be subject to accelerated income inclusion, an additional 20% federal tax, and interest. The 2025 Plan is intended to be administered in a manner consistent with applicable Code Section 409A requirements, but participants should consult their own tax advisors regarding the application of Code Section 409A to their awards.

**Special Note for Non-U.S. Participants**

Participants who are resident, employed or otherwise subject to tax outside the United States may be subject to tax, securities, exchange control, labor, social insurance and other rules that differ from U.S. rules. The Committee may modify awards or establish sub-plans for participants outside the United States to comply with local requirements or to preserve intended benefits. This Summary does not provide tax advice for any non-U.S. jurisdiction. Non-U.S. participants should consult their own tax advisors regarding the tax and other consequences of participation in the 2025 Plan.

**Where You Can Find More Information**

The Company files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and other information with the SEC. The Company's SEC filings are available to the public over the Internet at the SEC's website, www.sec.gov. You also may request copies of the documents described below, without charge, by writing or calling the Company at the following address and telephone number:

Future FinTech Group Inc.<br> 02B-03A, 23/F, Sino Plaza, 255-257 Gloucester Road<br> Causeway Bay, Hong Kong<br> Attention: Hu Li<br> Telephone: 00852-21141970

Email: leehoo@ftft.com

The SEC allows the Company to "incorporate by reference" information into this Section 10(a) prospectus, which means that the Company can disclose important information to you by referring you to documents filed with the SEC. The information incorporated by reference is an important part of this prospectus. Information that the Company files later with the SEC will automatically update and supersede information pertaining to the same subject in this prospectus or in earlier filings. The Company incorporates by reference into this prospectus the documents listed below and any future filings made by the Company with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, until the Company files a post-effective amendment indicating that all securities offered have been sold or deregistering all securities then remaining unsold. Documents, reports and definitive proxy or information statements, or portions of them, that are furnished and not filed under SEC rules are not incorporated by reference unless specifically stated otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;(1) The Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2025, filed with the SEC on March 18, 2026 (File No. 001-34502).

&nbsp;&nbsp;&nbsp;&nbsp;(2) All other reports filed by the Company pursuant to Section
13(a) or 15(d) of the Exchange Act since December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;(3) The description of the Company's Common Stock contained
in the Company's registration statement filed under Section 12 of the Exchange Act, including any amendment or report filed for
the purpose of updating that description, including the description of securities filed as Exhibit 4.1 to the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2025.

The Company has filed, or intends to file, a Registration Statement on Form S-8 with the SEC covering the shares of Common Stock authorized for issuance under the 2025 Plan.

The Company will provide to each participant, without charge and upon written or oral request, copies of the documents incorporated by reference in this prospectus and other documents required to be delivered under Rule 428(b) under the Securities Act. The Company will not provide exhibits to these documents unless the exhibits are specifically incorporated by reference into the documents that this prospectus incorporates by reference.

You should rely only on the information incorporated by reference or provided in this Summary, the 2025 Plan, the applicable award agreement, and any prospectus supplement or updating materials provided by the Company. The Company has not authorized anyone to provide you with different information. You should not assume that the information in this Summary, any prospectus supplement or any incorporated document is accurate as of any date other than the date of that document, except to the extent the information is updated or superseded by later information provided or incorporated by reference.

This Summary is intended as a plain English summary of the 2025 Plan and may become outdated if the 2025 Plan is amended or the Company's policies change. Always refer to the 2025 Plan and your award agreement when a question arises regarding your award or participation in the 2025 Plan. A copy of the 2025 Plan was provided to you. To obtain another copy of the 2025 Plan, an award agreement, or additional information about the 2025 Plan and its administrator, please contact the Company at the address, telephone number or email address listed above.

No person has been authorized to give any information or to make any representations not contained in or incorporated by reference into this Summary. If any such information or representation is given or made, you should not rely on it as having been authorized by the Company. Neither delivery of this Summary nor any issuance or sale of shares under the 2025 Plan will under any circumstances create any implication that there has been no change in the affairs of the Company since the date of this Summary or since the date of any document incorporated by reference. This Summary does not constitute an offer to sell or a solicitation of an offer to purchase any securities other than the securities to which this Summary relates, or an offer or solicitation in any jurisdiction or to any person to whom it is unlawful to make such offer or solicitation.

## Exhibit 5.1

**Exhibit 5.1**

![](ea029244101_ex5-1img1.jpg)

---

| | |
|:---|:---|
| ***LAURA ANTHONY, ESQ.***<br> ***CRAIG D. LINDER, ESQ.\****<br> ***JOHN CACOMANOLIS, ESQ.\*\****<br>***Associates and OF COUNSEL:***<br> ***JOSEPHINE CARINO, ESQ.\*\*\****<br> ***CHAD FRIEND, ESQ., LLM***<br> ***MICHAEL R. GEROE, ESQ., CIPP/US\*\*\*\****<br> ***JESSICA HAGGARD, ESQ. \*\*\*\*\****<br> ***PETER P. LINDLEY, ESQ., CPA, MBA***<br> ***JOHN LOWY, ESQ.\*\*\*\*\*\****<br> ***STUART REED, ESQ.***<br> ***LAZARUS ROTHSTEIN, ESQ.***<br> ***SVETLANA ROVENSKAYA, ESQ.\*\*\*\*\*\*\****<br> ***HARRIS TULCHIN, ESQ. \*\*\*\*\*\*\*\**** | **<u>WWW.ALCLAW.COM</u>**<br> **<u>WWW.SECURITIESLAWBLOG.COM</u>**<br>***DIRECT E-MAIL: LANTHONY@ALCLAW.COM***<br>|

---

\*licensed in CA, FL and NY

\*\*licensed in FL and NY

\*\*\*licensed in CA

\*\*\*\*licensed in CA, DC, MO and NY

\*\*\*\*\*licensed in CA and DC

\*\*\*\*\*\*licensed in NY and NJ

\*\*\*\*\*\*\*licensed in NY and NJ

\*\*\*\*\*\*\*\*licensed in CA and HI (inactive in HI)

May 29, 2026

Future FinTech Group Inc.

02B-03A, 23/F, Sino Plaza, 255-257 Gloucester Road

Causeway Bay, Hong Kong

**Re: Registration Statement on Form S-8**

Ladies and Gentlemen:

We have examined the Registration Statement on Form S-8 (the "Registration Statement") to be filed by Future FinTech Group Inc., a Florida corporation (the "Company"), with the Securities and Exchange Commission (the "Commission") under the Securities Act of 1933, as amended (the "Securities Act"), relating to 1,250,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock"), issuable pursuant to the Future FinTech Group Inc. 2025 Omnibus Equity Plan (the "Plan"). The shares of Common Stock issuable pursuant to the Plan are collectively referred to herein as the "Shares".

In that connection, we have examined originals, or copies certified or otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we have deemed necessary or appropriate for the purposes of this opinion, including, without limitation: (a) the Second Amended and Restated Articles of Incorporation, as amended, of the Company; (b) the Amended and Restated Bylaws of the Company; (c) certain resolutions adopted by the Board of Directors of the Company; and (d) the Plan.

In rendering our opinion, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as duplicates or copies. As to all questions of fact material to this opinion that have not been independently established, we have relied upon certificates or comparable documents of officers and representatives of the Company.

Based on the foregoing and in reliance thereon, and subject to compliance with applicable state securities laws, we are of the opinion that the Shares when, and if, issued pursuant to the terms of the Plan will be validly issued, fully paid and non-assessable.

Our opinion expressed herein is limited to the internal laws of the State of Florida and the federal laws of the United States, and we do not express any opinion herein concerning any other law.

We hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Registration Statement. In giving this consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

---

| |
|:---|
| Very truly yours, |
| ANTHONY, LINDER & CACOMANOLIS, PLLC |
| /s/ Laura Anthony |

---

**1700 Palm Beach Lakes Blvd., Suite 820 ● West Palm Beach, Florida ● 33401 ● PHONE: 561-514-0936 ● FAX 561-514-0832**

## Exhibit 23.1

**Exhibit 23.1**

---

| | |
|:---|:---|
| ![](ea029244101_ex23-1img1.jpg) | 12361 Lewis St Ste 202 Garden Grove, CA 92840<br> Phone (714)-820-3316 Fax (714)-333-4992 |

---

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the inclusion by reference in this Registration Statement on Form S-8 of Future FinTech Group Inc. ("the Company") of our report dated March 18. 2026, relating to our audits of the consolidated financial statements of the Company as of and for the years ended December 31, 2025 and 2024 which are included in the Company's Annual Report on Form 10-K and incorporated by reference in this Registration Statement. We also consent to the reference to our firm under the heading "Experts" in such Registration Statement.

/s/ Fortune CPA, Inc.

Garden Grove, California

May 29, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**S-8**

**Future FinTech Group Inc.**

**Table 1: Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Common Stock, par value $0.001 per share | (1) | Other | 1250000 | $1.19 | $1487500.00 | 0.0001381 | $205.62 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $1487500.00 |  | 205.62 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $205.62 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Represents shares of Common Stock issuable under the Future FinTech Group Inc. 2025 Omnibus Equity Plan. Pursuant to Rule 416(a) under the Securities Act, this Registration Statement also covers an indeterminate number of additional shares of Common Stock that may become issuable under the Plan to prevent dilution resulting from any stock dividend, stock split, recapitalization or other similar transaction. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, based on the average of the high and low prices of the Registrant's Common Stock as reported on The Nasdaq Capital Market on May 27, 2026, a date within five business days of the filing date.